(VIANEWS) – Ritchie Bros. Auctioneers Incorporated (RBA), Amphastar Pharmaceuticals (AMPH), TriMas Corporation (TRS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Ritchie Bros. Auctioneers Incorporated (RBA)
123.7% sales growth and 4.41% return on equity
Ritchie Bros. Auctioneers Incorporated, an asset management and disposition company, sells industrial equipment and other durable assets through its unreserved auctions, online marketplaces, listing services, and private brokerage services. It sells a range of used and unused commercial assets, including earthmoving equipment, truck tractors and trailers, government surplus, oil and gas equipment, and other industrial assets, as well as construction and heavy machinery. The company also offers live auction events with online bidding. It sells used equipment to its customers through live unreserved auctions at 40 auction sites worldwide. The company serves construction, transportation, agriculture, energy, oil and gas, mining, and forestry sectors. It operates in the United States, Canada, Australia, the United Arab Emirates, the Netherlands, Europe, the Middle East, Asia, and internationally. Ritchie Bros. Auctioneers Incorporated was founded in 1958 and is headquartered in Burnaby, Canada.
Earnings Per Share
As for profitability, Ritchie Bros. Auctioneers Incorporated has a trailing twelve months EPS of $1.08.
PE Ratio
Ritchie Bros. Auctioneers Incorporated has a trailing twelve months price to earnings ratio of 62. Meaning, the purchaser of the share is investing $62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.41%.
Volume
Today’s last reported volume for Ritchie Bros. Auctioneers Incorporated is 249759 which is 84.45% below its average volume of 1606320.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Aug 21, 2023, the estimated forward annual dividend rate is 1.08 and the estimated forward annual dividend yield is 1.61%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Ritchie Bros. Auctioneers Incorporated’s EBITDA is 47.29.
2. Amphastar Pharmaceuticals (AMPH)
36.7% sales growth and 18.73% return on equity
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Earnings Per Share
As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $1.83.
PE Ratio
Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 25.01. Meaning, the purchaser of the share is investing $25.01 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.73%.
Volume
Today’s last reported volume for Amphastar Pharmaceuticals is 638319 which is 40.43% above its average volume of 454520.
Moving Average
Amphastar Pharmaceuticals’s value is below its 50-day moving average of $50.80 and higher than its 200-day moving average of $43.84.
Previous days news about Amphastar Pharmaceuticals(AMPH)
- Amphastar pharmaceuticals (amph) laps the stock market: here's why. According to Zacks on Monday, 16 October, "On that day, Amphastar Pharmaceuticals is projected to report earnings of $0.70 per share, which would represent year-over-year growth of 84.21%. ", "Any recent changes to analyst estimates for Amphastar Pharmaceuticals should also be noted by investors. "
3. TriMas Corporation (TRS)
23.2% sales growth and 7.43% return on equity
TriMas Corporation manufactures and provides products for consumer products, aerospace, and industrial end markets worldwide. It operates in three segments: Packaging, Aerospace, and Specialty Products. The Packaging segment offers specialty polymeric and steel closure and dispensing systems, including dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, flexible spouts, and agricultural closures; polymeric jar products; integrated dispensers; bag-in-box products; aseptic closures; industrial closures and flex spouts; and single-bodied and assembled caps and closures under the Rieke, Taplast, Affaba & Ferrari, Stolz, and Rapak brands. The Aerospace segment provides fasteners, collars, blind bolts, rivets, ducting and connectors for air management systems, and machined parts and components to original equipment manufacturers, supply chain distributors, MRO/aftermarket providers, and tier one suppliers for commercial, maintenance, repair, and operations (MRO); and military and defense aerospace applications and platforms under the Monogram Aerospace Fasteners, Allfast Fastening Systems, Mac Fasteners, RSA Engineered Products, and Martinic Engineering brands. The Specialty Products segment offers steel cylinders for use in the transportation, storage, and dispensing of compressed gases under the Norris Cylinder brand; natural gas powered wellhead engines, compressors, and replacement parts for oil and natural gas production, and other industrial and commercial markets under the Arrow brand; and spare parts for various industrial engines. The company sells its products through a direct sales force, third-party agents, and distributors. TriMas Corporation was incorporated in 1986 and is headquartered in Bloomfield Hills, Michigan.
Earnings Per Share
As for profitability, TriMas Corporation has a trailing twelve months EPS of $1.14.
PE Ratio
TriMas Corporation has a trailing twelve months price to earnings ratio of 21.72. Meaning, the purchaser of the share is investing $21.72 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.43%.
4. ANSYS (ANSS)
18% sales growth and 11.19% return on equity
ANSYS, Inc. develops and markets engineering simulation software and services worldwide. It offers ANSYS Workbench, a framework upon which its multiphysics engineering simulation technologies are built and enables engineers to simulate the interactions between structures, heat transfer, fluids, electronics, and optical elements in a unified engineering simulation environment; high-performance computing product suite and the cloud; power analysis and optimization software suite that manages the power budget, power delivery integrity, and power-induced noise in an electronic design; and structural analysis product suite that provides simulation tools for product design and optimization. The company also provides electronics product suite that offers electromagnetic field simulation software for designing electronic and electromechanical products; SCADE product suite, a solution for embedded software simulation, code production, and automated certification; fluids product suite that enables modeling of fluid flow and other related physical phenomena; Ansys Granta products to give access to material intelligence; photonic design and simulation tools; and optical sensor and closed-loop, and real-time simulation, as well as safety-certified embedded software solutions. In addition, the company provides Discovery product family for use in the simulation of product design; and academic product suite used in research and teaching settings, which allows students to become familiar with its simulation software. It serves engineers, designers, researchers, and students in the aerospace and defense, automotive, construction, consumer products, energy, healthcare, high-tech, industrial equipment, and materials and chemical processing industries. ANSYS, Inc. was founded in 1970 and is headquartered in Canonsburg, Pennsylvania.
Earnings Per Share
As for profitability, ANSYS has a trailing twelve months EPS of $6.
PE Ratio
ANSYS has a trailing twelve months price to earnings ratio of 50. Meaning, the purchaser of the share is investing $50 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.19%.
Sales Growth
ANSYS’s sales growth is negative 0.8% for the current quarter and 18% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ANSYS’s EBITDA is 287.2.
5. Terreno Realty Corporation (TRNO)
9% sales growth and 6.07% return on equity
Terreno Realty Corporation and together with its subsidiaries, the “Company”) acquires, owns and operates industrial real estate in six major coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. All square feet, acres, occupancy and number of properties disclosed in these condensed notes to the consolidated financial statements are unaudited. As of September 30, 2020, the Company owned 219 buildings aggregating approximately 13.1 million square feet, 22 improved land parcels consisting of approximately 85.0 acres and one property under redevelopment expected to contain approximately 0.2 million square feet upon completion. The Company is an internally managed Maryland corporation and elected to be taxed as a real estate investment trust (“REIT”) under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended (the “Code”), commencing with its taxable year ended December 31, 2010.
Earnings Per Share
As for profitability, Terreno Realty Corporation has a trailing twelve months EPS of $1.84.
PE Ratio
Terreno Realty Corporation has a trailing twelve months price to earnings ratio of 30.2. Meaning, the purchaser of the share is investing $30.2 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.07%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 21.7%, now sitting on 300.99M for the twelve trailing months.
Moving Average
Terreno Realty Corporation’s worth is under its 50-day moving average of $58.99 and below its 200-day moving average of $60.74.
Sales Growth
Terreno Realty Corporation’s sales growth is 14.5% for the ongoing quarter and 9% for the next.
Yearly Top and Bottom Value
Terreno Realty Corporation’s stock is valued at $55.57 at 06:22 EST, way below its 52-week high of $67.03 and higher than its 52-week low of $51.45.
6. Credicorp Ltd. (BAP)
7% sales growth and 18.2% return on equity
Credicorp Ltd., a financial services holding company, provides various financial, insurance, and health services and products primarily in Peru and internationally. The company's Universal Banking segment offers deposits and current accounts, and various credits and financial instruments to individuals and legal entities. Its Insurance and Pensions segment issues insurance policies to cover losses in commercial property, transportation, marine vessels, automobile, life, health, and pensions, as well as provides private pension fund management services. The company's Microfinance segment manages loans, credits, deposits, and current accounts of the small and microenterprises. Its Investment Banking and Wealth Management segment offers its services to corporations, institutional investors, governments, and foundations; engages in structuring and placement of issues in the primary market, as well as the execution and negotiation of operations in the secondary market; and structures securitization processes for corporate customers and manages mutual funds. The company was founded in 1889 and is headquartered in Lima, Peru.
Earnings Per Share
As for profitability, Credicorp Ltd. has a trailing twelve months EPS of $16.6.
PE Ratio
Credicorp Ltd. has a trailing twelve months price to earnings ratio of 7.64. Meaning, the purchaser of the share is investing $7.64 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.2%.
7. Getty Realty Corporation (GTY)
6.8% sales growth and 8.44% return on equity
Getty Realty Corp. is the leading publicly traded real estate investment trust in the United States specializing in the ownership, leasing and financing of convenience store and gasoline station properties. As of September 30, 2020, the Company owned 896 properties and leased 58 properties from third-party landlords in 35 states across the United States and Washington, D.C.
Earnings Per Share
As for profitability, Getty Realty Corporation has a trailing twelve months EPS of $1.4.
PE Ratio
Getty Realty Corporation has a trailing twelve months price to earnings ratio of 19.82. Meaning, the purchaser of the share is investing $19.82 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.44%.
Yearly Top and Bottom Value
Getty Realty Corporation’s stock is valued at $27.75 at 06:22 EST, way below its 52-week high of $36.49 and higher than its 52-week low of $26.33.
Volume
Today’s last reported volume for Getty Realty Corporation is 35915 which is 87.77% below its average volume of 293675.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Sep 26, 2023, the estimated forward annual dividend rate is 1.72 and the estimated forward annual dividend yield is 6.28%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 14.8% and a drop 43.9% for the next.
8. AMETEK (AME)
5.9% sales growth and 16.43% return on equity
AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices in North America, Europe, Asia, and South America. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.Its EMG segment offers engineered electrical connectors and electronics packaging to protect sensitive devices and mission-critical electronics; precision motion control products for data storage, medical devices, business equipment, automation, and other applications; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for use in thermal management, military, commercial aircraft, and military ground vehicles; and motors for use in commercial appliances, fitness equipment, food and beverage machines, hydraulic pumps, and industrial blowers. This segment also operates a network of aviation maintenance, repair, and overhaul facilities. In addition, the company offers clinical and educational communication solutions. AMETEK, Inc. was incorporated in 1930 and is headquartered in Berwyn, Pennsylvania.
Earnings Per Share
As for profitability, AMETEK has a trailing twelve months EPS of $5.34.
PE Ratio
AMETEK has a trailing twelve months price to earnings ratio of 28.12. Meaning, the purchaser of the share is investing $28.12 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.43%.
